Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.
Glyconics has raised $2.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.
Glyconics's investors include Innovate UK, Deepbridge Capital, Boundary Capital Partners LLP, Wealth Club, SBRI Healthcare.
Glyconics is headquartered in Cambridge, United States.
Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.
Glyconics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Glyconics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/glyconics. Accessed August 14, 2026.
VCBacked. (2021). Glyconics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/glyconics
{{cite web |title=Glyconics — Funding & Investors |url=https://www.vcbacked.co/company/glyconics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated